162 related articles for article (PubMed ID: 2171758)
1. Role of transforming growth factor beta in the proliferative effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on human squamous carcinoma cells.
Hébert CD; Cao QL; Birnbaum LS
Cancer Res; 1990 Nov; 50(22):7190-7. PubMed ID: 2171758
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of high-density growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Hébert CD; Cao QL; Birnbaum LS
Carcinogenesis; 1990 Aug; 11(8):1335-42. PubMed ID: 2387019
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell lines.
Rowlands C; Krishnan V; Wang X; Santostefano M; Safe S; Miller WR; Langdon S
Cancer Res; 1993 Apr; 53(8):1802-7. PubMed ID: 8385571
[TBL] [Abstract][Full Text] [Related]
5. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
6. Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated CYP1A1 and CYP1B1 induction by 12-O-tetradecanoylphorbol-13-acetate: role of transforming growth factor beta and mitogen-activated protein kinases.
Guo M; Joiakim A; Dudley DT; Reiners JJ
Biochem Pharmacol; 2001 Dec; 62(11):1449-57. PubMed ID: 11728381
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control.
Gaido KW; Maness SC; Leonard LS; Greenlee WF
J Biol Chem; 1992 Dec; 267(34):24591-5. PubMed ID: 1447203
[TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as growth modulator in mouse hepatocytes with high and low affinity Ah receptor.
Schrenk D; Schäfer S; Bock KW
Carcinogenesis; 1994 Jan; 15(1):27-31. PubMed ID: 8293544
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1 inhibits TCDD-induced cytochrome P450IA1 expression in human lung cancer A549 cells.
Vogel C; Döhr O; Abel J
Arch Toxicol; 1994; 68(5):303-7. PubMed ID: 8085941
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Gaido KW; Maness SC
Toxicol Appl Pharmacol; 1994 Aug; 127(2):199-208. PubMed ID: 8048063
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S
Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta1 is not involved in 2,3,7,8-tetrachlorodibenzo- p-dioxin-dependent release from contact-inhibition in WB-F344 cells.
Hoelper P; Faust D; Oesch F; Dietrich C
Arch Toxicol; 2004 Nov; 78(11):643-8. PubMed ID: 15292977
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 coregulates mRNA expression of aryl hydrocarbon receptor and cell-cycle-regulating genes in human cancer cell lines.
Döhr O; Abel J
Biochem Biophys Res Commun; 1997 Dec; 241(1):86-91. PubMed ID: 9405238
[TBL] [Abstract][Full Text] [Related]
14. Expression of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P4501A1 in human splenic lymphocyte cultures.
Jeong HG; Yang KH
Cancer Lett; 1996 Jan; 98(2):193-8. PubMed ID: 8556708
[TBL] [Abstract][Full Text] [Related]
15. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.
Vanden Heuvel JP; Clark GC; Kohn MC; Tritscher AM; Greenlee WF; Lucier GW; Bell DA
Cancer Res; 1994 Jan; 54(1):62-8. PubMed ID: 8261464
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 is not involved in TCDD-dependent release from contact inhibition in WB-F344 cells.
Hoelper P; Faust D; Oesch F; Dietrich C
Arch Toxicol; 2005 Jan; 79(1):31-6. PubMed ID: 15448980
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells.
Merchant M; Krishnan V; Safe S
Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116
[TBL] [Abstract][Full Text] [Related]
18. The actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin on transforming growth factor-beta2 promoter activity are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway.
Lee DC; Barlow KD; Gaido KW
Toxicol Appl Pharmacol; 1996 Mar; 137(1):90-9. PubMed ID: 8607146
[TBL] [Abstract][Full Text] [Related]
19. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
Blank JA; Tucker AN; Sweatlock J; Gasiewicz TA; Luster MI
Mol Pharmacol; 1987 Jul; 32(1):169-72. PubMed ID: 3037301
[TBL] [Abstract][Full Text] [Related]
20. Induction of ethoxyresorufin-O-deethylase and inhibition of glucocorticoid receptor binding in skin and liver of haired and hairless HRS/J mice by topically applied 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Stohs SJ; Abbott BD; Lin FH; Birnbaum LS
Toxicology; 1990 Dec; 65(1-2):123-36. PubMed ID: 2274963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
